SALS
Showing 1 - 9 of 9
Sporadic Amyotrophic Lateral Sclerosis Trial in United States (Mexiletine, Placebo)
Completed
- Sporadic Amyotrophic Lateral Sclerosis
- Mexiletine
- Placebo
-
Los Angeles, California
- +9 more
Sep 27, 2021
Motor Neuron Disease, Amyotrophic Lateral Sclerosis Trial in Berlin
Recruiting
- Motor Neuron Disease, Amyotrophic Lateral Sclerosis
-
Berlin, GermanyCenter for ALS and other motor neuron disorders, Charité - Unive
May 2, 2023
Sporadic Amyotrophic Lateral Sclerosis Trial in United States (Mexiletine, Placebo)
Completed
- Sporadic Amyotrophic Lateral Sclerosis
- Mexiletine
- Placebo
-
Phoenix, Arizona
- +9 more
Nov 17, 2019
Macrophages From Patients Affected by ALS or Other Related Motor
Recruiting
- Amyotrophic Lateral Sclerosis
-
Paris, FranceDépartement de Neurologie, Hôpital de la Pitié-Salpêtrière
May 24, 2022
Amyotrophic Lateral Sclerosis Trial in Beijing (Amyotrophic Lateral Sclerosis)
Not yet recruiting
- Amyotrophic Lateral Sclerosis
- Amyotrophic Lateral Sclerosis
-
Beijing, ChinaBeijing Tiantan Hospital
May 28, 2023
Familial and Sporadic ALS/Motor Neuron Disease, Miyoshi Myopathy
Enrolling by invitation
- Amyotrophic Lateral Sclerosis
- +9 more
-
Worcester, MassachusettsUniversity of Massachusetts Medical School
May 16, 2022
Circulating Biomarker for Amyotrophic Lateral Sclerosis (ALS)
Recruiting
- Amyotrophic Lateral Sclerosis (ALS)
-
Pozzilli, ItalyIRCCS Neuromed
May 18, 2022
l Modifications ofCritical Protein Implicated in Amyotrophic
Completed
- ALS
-
Chapel Hill, North CarolinaUNC Neurology ALS clinic
Oct 16, 2018
Amyotrophic Lateral Sclerosis Trial in Burlington (Creatinine)
Completed
- Amyotrophic Lateral Sclerosis
-
Burlington, VermontUniversity of Vermont
Jun 23, 2005